Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01780675 : Hippocampus Avoidance PCI vs PCI
PhasePhase 3
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- ? Small Cell Lung Cancer patients (stage I-III or stage IV without clinical or
radiological evidence of brain metastases) candidate for PCI, i.e. without
progressive disease after chemo-radiotherapy in stage I-III or after a remission
after chemotherapy in stage IV

- Sufficient proficiency in Dutch

Exclusion Criteria:

- Prior radiotherapy to the brain

- Clinical evidence for brain metastases or primary brain tumors? Evidence of
progressive extracranial metastatic disease

- Previous malignancy < 2 years ago except for adequately treated basal cell carcinoma
of the skin and carcinoma in situ of the cervix

- Any systemic anticancer treatment during PCI or within 3 weeks before start PCI

- Pregnancy or lactation
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01780675      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740